Oramed Provides Update on Oravax: Oral Vaccine Maker Gets IRB Approval for Clinical Trial
– Oravax’s virus-like particle (VLP) vaccine being tested against COVID-19 variants including Delta – Oravax signs licensing deal for VLP injectable vaccine technology with Premas Biotech for commercialization in India NEW YORK, July 21, 2021 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug […]
